CD4 and neoplasm: showed that CD4+ T cells and antibodies recognizing similarly a tumor neo-antigen derived from somatic mutations of the self-antigen RCP1 (the large subunit of RNA polymerase 3) and its wild type form can be detected in patients with cancer-associated scleroderma (60).